ISTH/LinkedIn
May 19, 2026, 15:57
Explore the Emerging Science Behind Factor XI/XIa Inhibition on the ISTH Academy – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“What if stroke prevention didn’t have to come with the same level of bleeding risk?
Explore the emerging science behind factor XI/XIa inhibition in this new learning resource on the ISTH Academy.
Review the role of FXI in thrombosis and hemostasis, examine key clinical trial data and discover how these therapies may reshape secondary stroke prevention.
- Includes real-world clinical scenarios
- CME credit available upon completion
Start learning today with the ISTH Academy.”
Other posts featuring International Society on Thrombosis and Haemostasis on Hemostasis Today.
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema
-
Jul 7, 2026, 05:40Andrew Agwunobi: UConn Health is Proud to Advance Stroke Rehabilitation for Veterans
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention